The 2023 Consumer Expenditure Survey is out -- and boy has it got some things to tell us about how we're spending our money.

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is working with ARS ...

In a report released today, Jailendra Singh from Truist Financial assigned a Hold rating to GoodRx Holdings (GDRX – Research Report). The ...

Wells Fargo upgraded GoodRx Holdings Inc (NASDAQ:GDRX), noting 2024 guidance has good visibility with upside potential to both estimates & valuation multiples. Wells Fargo analyst anticipates that ...

Navigating the complex world of prescription drug pricing can feel overwhelming, particularly with the ever-increasing costs ...

“That’s what virtually any pharmacist would recommend,” he said. GoodRx gave the same advice, though it singled out that ...

Goodrx Holdings Inc (GDRX) stock saw a decline, ending the day at $7.59 which represents a decrease of $-0.09 or -1.17% from the prior close of $7.68. The stock opened at $7.75 and touched a low of $7 ...

One option for consumers is GoodRx, a company that aims to make drug pricing more transparent while giving consumers access to discounts on prescription medications. But what are the pros and cons and ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Karla Robinson, MD and Medical Editor at GoodRx discusses how GLP-1 receptor agonists work and their benefits.

The free mammogram screening event will be held this Sunday, Sept. 29, at St. Joseph and St. Mary Immaculate, located at 463 ...

With health insurance covering most of the costs, the out-of-pocket monthly expenses for Ozempic can range between $25 to ...